NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Tasso

Tasso

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://www.tassoinc.com/

Last Round

Series B

Dec 16, 2021

Total Funding Raised

$126.57M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Tasso is a healthcare technology company that produces innovative blood collection devices designed for easy and virtually painless self-collection of blood samples.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

at-home blood collectiondecentralized clinical trialsremote patient monitoringdried blood spotDBSvirtually painless blood drawDCTRPMfinger-prick testingphlebotomy alternativeclinical diagnostic testingsample collection devicepatient-centric diagnosticshome health techmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tasso Comps

Public and private peers based on sector, stage, and business model.

Tasso comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Tasso Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 16, 2021
Series AJul 22, 2020
VC RoundMar 5, 2019
SeedDec 6, 2017
GrantSep 28, 2017
Grant
Apr 7, 2015

Key People

Founding team and executive leadership

Erwin Berthier

CTO And Co-Founder

Founding Team

Monica W.

Chief Financial Officer

Executive Team

Tasso Investors

Notable investors and investment history

Tasso investors
InvestorRounds
Senvest CapitalSeries B
RA Capital ManagementSeries B
TechstarsSeed, Series A, VC Round
Senvest ManagementSeries B
NIH RADxGrant
InCube VenturesSeries B
SVB Innovation Credit Fund VIII, L.P.Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Olympic anti-doping program is using their products.

  • Feb 26, 2026

    Developing at-home blood testing services in partnership with ARUP.

Tasso Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tasso Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tasso's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range101
Year Founded2012
Last FundingDec 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.